CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-03 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −417 | $453.51 | $189K | 20,436 |
| 2025-10-03 | Garg Pushkal EVP Chief R&D | Sale 10b5-1 | −215 | $454.37 | $98K | 20,221 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −150 | $446.53 | $67K | 57,723 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −73 | $447.92 | $33K | 57,650 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −234 | $448.77 | $105K | 57,416 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −324 | $449.79 | $146K | 57,092 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −704 | $450.81 | $317K | 56,388 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −432 | $451.86 | $195K | 55,956 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −869 | $452.69 | $393K | 55,087 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −428 | $453.77 | $194K | 54,659 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −317 | $454.84 | $144K | 54,342 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −95 | $455.82 | $43K | 54,247 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −191 | $457.43 | $87K | 54,056 |
| 2025-10-02 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −4 | $457.64 | $2K | 54,052 |
| 2025-10-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −350 | $446.53 | $156K | 73,983 |
| 2025-10-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −171 | $447.92 | $77K | 73,812 |
| 2025-10-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −548 | $448.77 | $246K | 73,264 |
| 2025-10-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −758 | $449.79 | $341K | 72,506 |
| 2025-10-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −1,642 | $450.81 | $740K | 70,864 |
| 2025-10-02 | Greenstreet Yvonne Chief Executive Officer | Sale | −1,010 | $451.86 | $456K | 69,854 |
Page 19 of 41 · 816 trades